CME Group Inc (CME) Shares Bought by CWA Asset Management Group LLC
CWA Asset Management Group LLC grew its stake in shares of CME Group Inc (NASDAQ:CME) by 9.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,380 shares of the financial services provider’s stock after purchasing an additional 1,428 shares during the quarter. CWA Asset Management Group LLC’s holdings in CME Group were worth $2,392,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently added to or reduced their stakes in the company. Caisse DE Depot ET Placement DU Quebec increased its stake in CME Group by 332.4% in the 4th quarter. Caisse DE Depot ET Placement DU Quebec now owns 33,691 shares of the financial services provider’s stock valued at $4,921,000 after buying an additional 25,900 shares during the period. Truewealth LLC acquired a new position in CME Group in the 4th quarter valued at $157,000. Parallel Advisors LLC increased its stake in CME Group by 57.8% in the 4th quarter. Parallel Advisors LLC now owns 1,862 shares of the financial services provider’s stock valued at $272,000 after buying an additional 682 shares during the period. MML Investors Services LLC increased its stake in CME Group by 26.8% in the 4th quarter. MML Investors Services LLC now owns 2,779 shares of the financial services provider’s stock valued at $406,000 after buying an additional 588 shares during the period. Finally, Amundi Pioneer Asset Management Inc. increased its stake in CME Group by 71.1% in the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 1,196,575 shares of the financial services provider’s stock valued at $174,759,000 after buying an additional 497,377 shares during the period. 82.59% of the stock is currently owned by institutional investors.
Several equities research analysts have commented on CME shares. Bank of America boosted their target price on shares of CME Group from $173.00 to $175.00 and gave the stock a “buy” rating in a research report on Friday, February 2nd. Zacks Investment Research upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 target price on the stock in a research report on Tuesday, January 2nd. Sandler O’Neill restated a “buy” rating and set a $175.00 target price on shares of CME Group in a research report on Friday, February 2nd. Barclays boosted their target price on shares of CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a research report on Friday, February 2nd. Finally, BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 10th. Three investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. CME Group currently has an average rating of “Buy” and a consensus target price of $157.00.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 EPS for the quarter, topping the consensus estimate of $1.10 by $0.02. The business had revenue of $900.00 million for the quarter, compared to analyst estimates of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The business’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.14 EPS. analysts anticipate that CME Group Inc will post 6.32 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Monday, March 26th. Shareholders of record on Friday, March 9th will be issued a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a yield of 1.68%. This is a positive change from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Thursday, March 8th. CME Group’s dividend payout ratio is 22.11%.
In other CME Group news, Director Ronald A. Pankau sold 200 shares of the company’s stock in a transaction dated Wednesday, February 14th. The shares were sold at an average price of $159.91, for a total value of $31,982.00. Following the transaction, the director now directly owns 3,809 shares in the company, valued at approximately $609,097.19. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Hilda Harris Piell sold 3,299 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $163.52, for a total transaction of $539,452.48. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 45,481 shares of company stock worth $6,989,671. 0.57% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: “CME Group Inc (CME) Shares Bought by CWA Asset Management Group LLC” was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.watchlistnews.com/cme-group-inc-cme-shares-bought-by-cwa-asset-management-group-llc/1909857.html.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.